Alpha 1A-adrenergic receptor polymorphism and vascular response

Area of Science:

• Pharmacology
• Genetics
• Cardiovascular Physiology

Background:

• The alpha(1A)-adrenergic receptor is crucial for smooth muscle contraction in human blood vessels.
• Genetic variations in this receptor influence individual responses to certain medications.
• Phenylephrine sensitivity, a measure of receptor activity, shows significant genetic influence.

Purpose of the Study:

• To investigate if the common Arg347Cys polymorphism in the alpha(1A)-adrenergic receptor gene impacts in vivo vascular response.
• To determine the effect of this specific genetic variation on phenylephrine-induced venoconstriction.

Main Methods:

• Vascular sensitivity to phenylephrine was measured using the dorsal hand vein linear variable differential transformer technique.
• Alpha(1A)-adrenergic receptor genotype (Arg/Arg, Arg/Cys, Cys/Cys) was determined in 74 healthy adults.
• Phenylephrine dose causing 50% venoconstriction (Phe(50)) was calculated for each genotype group.

Main Results:

• No significant difference in phenylephrine sensitivity (Phe(50)) was observed across the three alpha(1A)-adrenergic receptor genotypes.
• Geometric mean Phe(50) values were 513 ng/min (Arg/Arg), 431 ng/min (Arg/Cys), and 471 ng/min (Cys/Cys).
• Statistical analysis showed no significant impact of the Arg347Cys polymorphism on venoconstriction (P =.90).

Conclusions:

• The Arg347Cys polymorphism in the alpha(1A)-adrenergic receptor does not alter agonist-mediated venoconstriction in vivo.
• This specific genetic variation does not appear to be a significant determinant of vascular smooth muscle response to phenylephrine.
• Further research may explore other genetic or environmental factors influencing phenylephrine sensitivity.